• Human APIs PowderRespiratory Drugs Raw Material Antiviral Antibacterial Antipyretic Analgesics Antihistamine Drugs Antineoplastic Urinary System Drugs Endocrine System Other
  • Pharmaceutical IntermediatesPharmaceutical intermediates Heterocyclic Compound OLED material intermediate Diphenylamine intermediates Nutritional Supplements Pharmaceutical raw materials
  • Medicine ExcipientsFiller Solubilizers Coating material Disintegrant Excipient Iubricant Other
  • Veterinary raw materialsAntibacterial anti-inflammatory Respiratory Drugs Gastrointestinal Drugs Disinfectant Anthelmintics Antiviral drugs Sow health care Feed additives
  • About UsCompany profileQualificationQuality AssuranceService teamFactory TourR&D Center
  • Spectinomycin Dihydrochloride CAS 21736-83-4 Raw Powder

    • Spectinomycin Dihydrochloride CAS 21736-83-4 Raw Powder
    • Spectinomycin Dihydrochloride CAS 21736-83-4 Raw Powder
    • Spectinomycin Dihydrochloride CAS 21736-83-4 Raw Powder storehouse
    • Spectinomycin Dihydrochloride CAS 21736-83-4 Raw Powder quality testing
    • Spectinomycin Dihydrochloride CAS 21736-83-4 Raw Powder quality testing
    • Spectinomycin Dihydrochloride CAS 21736-83-4 Raw Powder certificate

    Product Overview:

    Spectinomycin Dihydrochloride Powder is an aminoglycoside antibiotic. By interfering with the synthesis of proteins in receptor bacteria, Spectinomycin Hydrochloride Antibiotics acts as an antibacterial agent, Spectinomycin Dihydrochloride Raw Powder is white or off-white powder. Spectomycin Hydrochloride Antibiotics: It is used for the treatment of chronic respiratory disease, enterotoxic syndrome, clostridial necrotizing enteritis caused by mixed infection of Mycoplasma, E. coli and Salmonella in poultry.

    Spectinomycin Dihydrochloride CAS 21736-83-4 Raw Powder Attributes

    Product Name: Spectinomycin Dihydrochloride CAS 21736-83-4 Raw Powder

    CAS: 21736-83-4

    MF: C14H25ClN2O7

    SPECTINOMYCIN DIHYDROCHLORIDE

    Specification​: 99% min Spectinomycin Dihydrochloride

    Sample:  Spectinomycin Dihydrochloride Powder

    Brand: Henrikang

    Appearance: White Powder

    Storage: Cool Dry Place

    Shelf Life: 2 Years

    Test Method: HPLC

    Spectinomycin Dihydrochloride CAS 21736-83-4 Raw Powder Details

    Spectinomycin Dihydrochloride Usage and Synthesis:

    Spectinomycin Dihydrochloride Powder is produced by Streptomyces; it is an aminoglycoside rapidly-bactericidal antibiotic composed of neutral sugars and aminocyclic alcohol-glycoside bonds; it is also known as splendycin. Daguanomycin hydrochloride is white or white powder. Spectinomycin Hydrochloride Antibiotics are used for the treatment of Escherichia coli, Salmonella, Pasteurella, mycoplasma and other diseases caused by sensitive bacterial infections. Daguanomycin hydrochloride for injection is a special drug for treating gonorrhea first developed by Lukang Medicine in China. Daguanomycin hydrochloride for injection is recommended as the preferred drug for gonorrhea by the World Health Organization (WHO) and the Ministry of Health. In terms of combined drug use for clinical oral treatment of livestock and poultry, Danguanomycin hydrochloride can be used in combination with common clinical drugs at present, and most of them show synergistic antibacterial effect. Since macromycin is an alkaline antibiotic, its antibacterial efficacy will be significantly enhanced when combined with some alkaline drugs, such as timicosain, talomycin, sodium bicarbonate, etc.

    Spectinomycin Hydrochloride Antibiotics

    Pharmacokinetics of Spectinomycin Dihydrochloride:

    Spectinomycin hydrochloride is an aminoglycoside antibiotic. It has a strong inhibitory effect on Gram-negative and positive bacteria and mycobacteria by interfering with protein synthesis in reactive bacteria. For example, it is effective against Staphylococcus aureus, Streptococcus, Escherichia coli, Salmonella, Pasteurella and mycobacteria and some Vibrio; very low toxicity; poorly absorbed orally, about 8-10% is absorbed by the intestinal tract. Daikonomycin hydrochloride is a broad-spectrum rapid bactericidal agent, which is more effective against Escherichia coli, Salmonella, Pasteurella, Aspergillus, Streptococcus haemolyticus, Streptococcus pneumoniae and Pneumocystis;

    Spectinomycin Hydrochloride

    therefore, it has a better clinical treatment effect on infectious diseases caused by the above sensitive bacteria. It has an inhibitory effect on Gram-positive and negative bacteria. It has strong antibacterial effect on gonococcus, and also has good antibacterial activity on B-lactamase-producing gonococcus, which is a new type of special drug for the treatment of gonorrhea. Daikonomycin is an alkaline antimicrobial agent, and the stronger the alkalinity, the stronger the antimicrobial efficacy; however, Daikonomycin is not soluble in water, so the most commonly used commercial original drug in China is Daikonomycin hydrochloride.

    Spectinomycin Hydrochloride Powder

    Clinical Application of Spectinomycin Dihydrochloride:

    Spectomycin Dichloride is used for the treatment of chronic respiratory disease, enterotoxic syndrome, clostridial necrotizing enteritis, pneumatocystitis, pericarditis, perihepatitis, etc. caused by mixed infections of Mycoplasma, E. coli, Salmonella, Pseudomonas aeruginosa, Pasteurella, Streptococcus in poultry; wheezing disease, pleuropneumonia, mycoplasma pneumonia, bronchitis, intractable diarrhea and dysentery in pigs. Like other aminoglycoside antimicrobials, the antimicrobial mechanism of daikonomycin hydrochloride is to selectively act on the 30s subunit of bacterial cell nucleoprotein body after entering the bacterial cell, thus producing a powerful inhibition of bacterial cell protein synthesis and a powerful killing effect on sensitive bacteria.

    Spectinomycin Hydrochloride Package

    Our advantage
    Our Factory
    Shipping
    Tel: 86-29-89601602
    WhatsApp: 8615091775531
    WeChat: 15091775531
    E-mail: sales21@interlgroup.com
    Add: Fengcheng 2nd Road, Weiyang District, Xi'an, Shaanxi, China
    ©2023 Xi'an Henrikang Biotech Co., Ltd.,